Sponsor Pipeline

Mert Ersan Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07466953
Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality		 Enrollment increased: 30 -> 40 participants
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07466953 Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality Skin Aging Not Yet Recruiting
Get alerts when Mert Ersan's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free